Get started

AARTI DRUGS LTD

No trades
See on Supercharts
Overview
News Ideas Financials Technicals Forecast

AARTIDRUGS chart

Key stats

Market capitalization
52.754BINR
Dividends yield (FY)
0.18%
Price to earnings Ratio (TTM)
29.45
Basic EPS (TTM)
19.35INR
Net income
1.663BINR
Revenue
27.161BINR
Shares float
92.6M
Beta
0.5

About AARTI DRUGS LTD

Sector
Health Technology
CEO
Prakash Moreshwar Patil
Headquarters
Mumbai
Website
aartidrugs.co.in
Employees
2.59K
Founded
1984
ISIN
INE767A01016

Aarti Drugs Ltd. engages in the development, manufacture and market of pharmaceutical products. The firm operates through the Out of India, and India geographical segments. Its products include active pharmaceutical ingredient, specialty chemicals, pharma intermediate, products under development, and product under pipeline. The company was founded on September 28, 1984 and is headquartered in Mumbai, India.

Ideas

📈 Exciting Bullish Pattern Alert! 🐂📈 Exciting Bullish Pattern Alert! 🐂 📊 Pattern: Falling Channel with Rounding Bottom 📌 Symbol/Asset: AARTIDRUGS 🔍 Description: Stock has given btrakout of falling channel and now prices are at law of polarity. After breakout we may see huge upside. 👉 Disclosure: We are not SEBI registered analyst
Long
AARTI DRUGS READY FOR 40% UPSIDEBUY AARTI DRUGS(W) above 510 for 40% upside. Inverse Head & Shoulder breakout confirmation will lead stock to test 620 to 700 and above. Moving averages showing golden crossover while volumes over buying side increasing exponentially.
Long
Will it BOThe rejection in July from 645 levels and the subsequent consolidation is very interesting. Only if it can BO and sustain above 645 the blue lines can become a possibility. --- --- --- The most important quality in the stock market is temperament, not intellect. - Warren Buffett
Long
AARTIDRUGS | Swing Trade📊 Details Established in the year 1984 and a part of $1000 million Aarti Group of Industries, Aarti Drugs Ltd. (ADL) is engaged into manufacturing and selling Active Pharmaceutical Ingredients (API's), Pharma Intermediates, Specialty Chemicals as well as Formulations. Disclaimer: This analysis
Long
AARTIDRUGS good time to enter!After a long period of time stocks is moving. A gap-up and breakout on 520 level with high volume indicating stock is accumulating by investors. Stock has also corrected a little from the high level and being ready to move again. Good time to take a position or swing trade. Maintain STOP LOSS. Ple
Long
AARTIDRUGSWe had an earnings gap up post which we can see a mini vcp formation near the trendline as depicted by the arcs..!! Now we also have a small shakeout in the base that is forming . the stock looks set for a nice leg of up move..can be a candidate for a continuation buy
Long
AartiDrugs - Weekly Chart AnalysisFirstly the stock have retraced to 50% and broke the down trendline and marks the end of downtrend with either sideways or an uptrend. The new swing high is formed with gap away candle. Now here, 2 possibilities can occur. Either it fills the gap and test previous resistance which shall act as a su
Long
AARTIDRUGS --- 30% POTENTIAL upside in short term NSE:AARTIDRUGS viewpoint the stock has given good breakout on weekly time frame around 440 levels cmp is 510 target can be 30% gains in short term this analysis is for knowledge sharing and educational purpose . this post is not a buy or sell recommendation.
Long

See all ideas 

News Flow

Keep readingKeep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Financials

Performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:—
‪0‬

Trading & brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
TradeStation
Featured
Stocks, Crypto, Futures
4.4Very Good
Learn more
Interactive Brokers
Interactive Brokers
Stocks, Futures, Bonds
4.3Good
Learn more

See all brokers